Protamine use for reversal of effects of heparin in PCI not tied to bleeding risk and stent thrombosis
Written By : Jacinthlyn Sylvia
Medically Reviewed By : Dr. Kamal Kant Kohli
Published On 2023-07-28 14:30 GMT | Update On 2023-10-19 11:09 GMT
Advertisement
A recent study published in the International Journal of Cardiology found evidence supporting the safety and efficacy of using protamine to reverse the effects of heparin in percutaneous coronary intervention (PCI) procedures.
Heparin, a commonly used anticoagulant during PCI, has been a standard practice in preventing clotting during the procedure. However, the use of protamine to reverse heparin's effects has been limited due to concerns about stent thrombosis, a potentially dangerous complication.
Our comments section is governed by our Comments Policy . By posting comments at Medical Dialogues you automatically agree with our Comments Policy , Terms And Conditions and Privacy Policy .
Disclaimer: This website is primarily for healthcare professionals. The content here does not replace medical advice and should not be used as medical, diagnostic, endorsement, treatment, or prescription advice. Medical science evolves rapidly, and we strive to keep our information current. If you find any discrepancies, please contact us at corrections@medicaldialogues.in. Read our Correction Policy here. Nothing here should be used as a substitute for medical advice, diagnosis, or treatment. We do not endorse any healthcare advice that contradicts a physician's guidance. Use of this site is subject to our Terms of Use, Privacy Policy, and Advertisement Policy. For more details, read our Full Disclaimer here.
NOTE: Join us in combating medical misinformation. If you encounter a questionable health, medical, or medical education claim, email us at factcheck@medicaldialogues.in for evaluation.